Cargando…
Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule
[Image: see text] In our overall goal to develop multifunctional dopamine D(2)/D(3) agonist drugs for the treatment of Parkinson’s disease (PD), we previously synthesized potent D(3) preferring agonist D-264 (1a), which exhibited neuroprotective properties in two animal models of PD. To enhance the...
Autores principales: | Modi, Gyan, Antonio, Tamara, Reith, Maarten, Dutta, Aloke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983390/ https://www.ncbi.nlm.nih.gov/pubmed/24471976 http://dx.doi.org/10.1021/jm401883v |
Ejemplares similares
-
[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl](phenyl)methanone
por: Kaur, Manpreet, et al.
Publicado: (2014) -
3-Chloro-6-{4-[3-(4-chlorophenoxy)propyl]piperazin-1-yl}pyridazine
por: Wang, Hongliang, et al.
Publicado: (2010) -
2-[4-(4-Methylphenylsulfonyl)piperazin-1-yl]-1-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)ethanone
por: Niu, Duan, et al.
Publicado: (2011) -
4,5,6,7-Tetrachloro-N-(2-fluorophenyl)phthalimide
por: Fu, Xian-Shu, et al.
Publicado: (2010) -
4,5,6,7-Tetrachloro-N-(2,3,4-trifluorophenyl)phthalimide
por: Zhang, Yin-Jun, et al.
Publicado: (2011)